Overview

Beta-Lactam Antibiotics InitiaL ExpoSure OptimisEd in CriticallY Ill Patients with SEpsis

Status:
RECRUITING
Trial end date:
2027-12-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to investigate if an initial short double dose of beta-lactam antibiotics will reduce mortality in critically ill patients with sepsis.
Phase:
PHASE4
Details
Lead Sponsor:
Erasmus Medical Center
Collaborators:
Albert Schweitzer Hospital
Maasstad Hospital